David Rosenbaum - Aug 21, 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Aug 21, 2023
Transactions value $
-$13,436
Form type
4
Date filed
8/23/2023, 04:45 PM
Previous filing
May 25, 2023
Next filing
Sep 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$10.1K -2.85K -0.76% $3.55 370K Aug 21, 2023 Direct F1, F2
transaction ARDX Common Stock Sale -$3.33K -937 -0.84% $3.55 111K Aug 21, 2023 By Wife F1, F3
holding ARDX Common Stock 77.6K Aug 21, 2023 Family Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F2 This transaction was executed in multiple trades in prices ranging from $3.5103 to $3.551843, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The shares are directly held by the Reporting Person's wife.
F4 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.